A network biology approach evaluating the anticancer effects of bortezomib identifies SPARC as a therapeutic target in adult T-cell leukemia cells

por Ohyashiki, Junko H, Hamamura, Ryoko, Kobayashi, Chiaki, Zhang, Yu, Ohyashiki, Kazuma
Publicado 2008

Impact on cell to plasma ratio of miR-92a in patients with acute leukemia: in vivo assessment of cell to plasma ratio of miR-92a

por Ohyashiki, Junko H, Umezu, Tomohiro, Kobayashi, Chiaki, Hamamura, Ryoko S, Tanaka, Masami, Kuroda, Masahiko, Ohyashiki, Kazuma
Publicado 2010